Interstitial lung disease associated with oxaliplatin: description of two cases

Clin Transl Oncol. 2009 May;11(5):332-3. doi: 10.1007/s12094-009-0364-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Colonic Neoplasms / drug therapy
  • Female
  • Fluorouracil / adverse effects
  • Humans
  • Leucovorin / adverse effects
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / pathology*
  • Male
  • Middle Aged
  • Organoplatinum Compounds / adverse effects*
  • Oxaliplatin

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol